Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Guillain-Barre Syndrome
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Other
Participants:
50
Start Date:
November 2021
Efficacy of Mini-pool Intravenous Immunoglobulin (MP-IVIG) Prepared by Assiut University Hospital Blood Bank in Guillain-Barré Syndrome
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
10
Start Date:
March 1, 2021
An Open-label Pilot Study to Evaluate the Safety and Efficacy of ADCT-301 in Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Myeloproliferative Neoplasms.
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Biological
Participants:
120
Start Date:
January 2021
NEUROKINASE : Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.
Clinical Trial
Status:
Recruiting
Phase:
Phase 2/Phase 3
Intervention Type:
Drug
Participants:
180
Start Date:
December 17, 2020
A Randomized, Double-blind, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of ANX005 in Subjects With Guillain-Barré Syndrome
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
18
Start Date:
November 2020
Phase I Trial To Evaluate The Safety Of CK0801 In Treatment-Resistant Guillain-Barré Syndrome (GBS)
Clinical Trial
Status:
Recruiting
Participants:
200
Start Date:
April 27, 2020
An Observational Cohort Study on the Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
24
Start Date:
January 29, 2020
A Phase 1b Study to Evaluate the Safety, Tolerability and Drug-Drug Interactions of ANX005 and Intravenous Immunoglobulin (IVIg) in Subjects With Guillain Barré Syndrome
Clinical Trial
Status:
Recruiting
Participants:
200
Start Date:
January 1, 2020
New Biomarkers in Acute and Chronic Inflammatory Demyelinating Polyradiculoneuropathies
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
30
Start Date:
November 12, 2019
An Open-label, Single Arm, Multi-centre, Phase II Study Investigating Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of Imlifidase in Patients With Guillain-Barré Syndrome, in Comparison With Matched Control Patients
Clinical Trial
Status:
Enrolling by invitation
Phase:
N/A
Intervention Type:
Diagnostic Test
Participants:
50
Start Date:
September 30, 2019
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome: A Pilot Study
Clinical Trial
Status:
Recruiting
Intervention Type:
Diagnostic Test
Participants:
100
Start Date:
July 1, 2019
Early Prediction of Respiratory and Autonomic Complications of GBS Using Neuromuscular Ultrasound
Clinical Trial
Status:
Recruiting
Participants:
500
Start Date:
September 8, 2014
Recovery After Cerebral Hemorrhage--Improving Outcomes for Patients With Life-Threatening Neurologic Illness
Showing 1-12 of 13
Next